Cause of death, by non-communicable diseases, ages 60+, male in Low income
Low income: Cause of death, by non-communicable diseases, ages 60+, male was 61.9% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 60+, male in Low income, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 60+.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 60+, male in Low income is 61.9%, measured in 2021.
That represents a change of down 10.2% on the previous year and down 8.8% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 60+, male in Low income peaked at 72.9% in 2019 and was at its lowest, 61.7%, in 2000.
That places Low income 33rd out of 47 groups with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 60+, male in Low income, year by year
| Year | % of total male deaths ages 60+ | Change |
|---|---|---|
| 2000 | 61.7% | — |
| 2010 | 67.8% | +10.0% |
| 2015 | 70.8% | +4.4% |
| 2019 | 72.9% | +2.9% |
| 2020 | 68.9% | -5.5% |
| 2021 | 61.9% | -10.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 61.7% | 61.7% | 61.7% | 1 |
| 2010s | 70.5% | 67.8% | 72.9% | 3 |
| 2020s | 65.4% | 61.9% | 68.9% | 2 |
Countries ranked near Low income
- 30 Puerto Rico 82.7% compare
- 31 United Arab Emirates 82.7% compare
- 32 Mongolia 82.5% compare
- 33 Switzerland 81.7% compare
- 34 Estonia 81.7% compare
- 35 Latvia 81.6% compare
- 36 Luxembourg 81.0% compare
More health data for Low income
- Population ages 40-44, female, per capita 0.0225 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, per capita 0.027 units per person (2025)
- Population ages 40-44, female, annual growth rate 3.49 % change on previous year (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, annual growth rate 3.59 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0218 units per person (2025)
- Population ages 35-39, male, annual growth rate 3.86 % change on previous year (2025)
- Population ages 40-44, male, annual growth rate 3.55 % change on previous year (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 60+, male in Low income?
- Cause of death, by non-communicable diseases, ages 60+, male in Low income was 61.9% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 60+, male recorded in Low income?
- The highest recorded value was 72.9% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 60+, male recorded in Low income?
- The lowest recorded value was 61.7% in 2000.
- How does Low income rank for cause of death, by non-communicable diseases, ages 60+, male?
- Low income ranks 33rd out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 60+, male rising or falling in Low income?
- Over the last ten years it is down 8.8%. The long-run trend across the full record is rising.
- Where does this Low income data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.